Radioimmunotherapy is more effective than antifungal treatment in experimental Cryptococcal Infection

Journal of Infectious Diseases

Volumn 202, Issue 4, 2010, Pages 633-637

  Bryan, Ruth A ^a   Jiang, Zewei ^a   Howell, Robertha C ^a   Morgenstern, Alfred ^d   Bruchertseifer, Frank ^d   Casadeval, Arturo ^a,b,c   Dadachova, Ekaterina ^a,b  

^a Departments of Nuclear Medicine   (United States)

^b Microbiology Immunology   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d JOINT RESEARCH CENTRE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FUNGUS ANTIBODY; GLUCURONOXYLOMANNAN BINDING MURINE MONOCLONAL ANTIBODY 18B7 BI 213; GLUCURONOXYLOMANNAN BINDING MURINE MONOCLONAL ANTIBODY 18B7 RE 188; IMMUNOGLOBULIN G1 ANTIBODY; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL RESISTANCE; ARTICLE; BRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FUNGAL CELL; FUNGAL STRAIN; FUNGUS CULTURE; HISTOPATHOLOGY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; SURVIVAL; WEIGHT CHANGE;

AMPHOTERICIN B; ANIMALS; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; BISMUTH; BRAIN; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE; RADIOIMMUNOTHERAPY; RADIOISOTOPES; TREATMENT OUTCOME;

EID: 77954690760     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/654813     Document Type: Article

References (15)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-530.
2. Ben-Ami R, Lewis, RE, Kontoyiannis DP. Immunopharmacology of modern antifungals. Clin Infect Dis 2008; 47:226-235.
3. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol 2003; 5:203-223.
4. Sharkey RM, Goldenberg DM. Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J Nucl Med 2005; 46(suppl 1):115S-127S.
5. Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 2003; 100:10942-10947.
6. Dadachova E, Bryan RA, Frenkel A, et al. Evaluation of acute hematological and long-term pulmonary toxicity of radioimmunotherapy of Cryptococcus neoformans infection in murine models. Antimicrob Agents Chemother 2004; 48:1004-1006.
7. Dadachova E, Bryan RA, Apostolidis C, et al. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. J Infect Dis 2006; 193:1427-1436.
8. Bryan RA, Jiang Z, Huang X et al. Radioimmunotherapy is effective against a high infection burden of Cryptococcus neoformans in mice and does not select for radiation-resistant phenotypes in cryptococcal cells. Antimicrob Agents Chemother 2009; 53:1679-1682.
9. Dadachova E, Howell RW, Bryan RA, Frenkel A, Nosanchuk JD, Casadevall A. Susceptibility of human pathogens Cryptococcus neoformans and Histoplasma capsulatum to g-radiation versus radioimmunotherapy with a-and b-emitting radioisotopes. J Nucl Med 2004; 45:313-320.
10. Dadachova E, Casadevall A. Ionizing radiation: how fungi cope, adapt and exploit with the help of melanin. Curr Opin Microbiol 2008; 11: 525-531.
11. Nosanchuk JD, Casadevall A. Budding of melanized Cryptococcus neoformans in the presence or absence of L-DOPA. Microbiology 2003; 149:1945-1951.
12. Nosanchuk JD, Rosas AL, Casadevall A. The antibody response to fungal melanin in mice. J Immunol 1998; 160:6026-6031.
13. Clemons KV, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42:899-902.
14. Kakeya H, Miyazaki Y, Senda H, et al. Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis. Antimicrob Agents Chemother 2008; 52:1871-1872.
15. Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis 2009; 49:702-709.